ScholarIQanswers from OpenAlex

Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI)

PaperCitations, authors & open-access status

Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) have?

ScholarIQcitation count

Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) has 10 citations in the OpenAlex counts ScholarIQ stores.

When was Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) published?

ScholarIQyear

Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) has 2024 year in the ScholarIQ index.

What is the open-access status of Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI)?

ScholarIQoa status

Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) has hybrid oa status in the ScholarIQ index.

What is the DOI of Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI)?

ScholarIQdoi

The DOI for Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) is on the source record.

What is the PMID of Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI)?

ScholarIQpmid

The PMID for Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) is on the source record.

What is the OpenAlex record for Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI)?

ScholarIQopenalex

The OpenAlex for Prospective multicentre observational study evaluating acute lower limb ischaemia (PROMOTE-ALI) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial